2019
DOI: 10.21873/invivo.11758
|View full text |Cite
|
Sign up to set email alerts
|

DNA Methylation in Human Breast Cancer Cell Lines Adapted to High Nitric Oxide

Abstract: Background: Nitric oxide (NO) exposure has been suggested to cause alterations in DNA methylation in breast cancer. We investigated the effect of NO on DNA methylation of promoters in cell lines of breast cancer. Material and Methods: The methylation status of the promoters of breast cancer 1 (BRCA1), deleted in colon cancer (DCC), Rasassociation domain family 1A (RASSF1A), O 6-methylguanine-DNA methyltransferase (MGMT), and secreted frizzled related protein 1 (SFRP1) were analyzed in the parental and high nit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 57 publications
0
1
0
Order By: Relevance
“…Successively, several array-based studies using different platforms have been performed to analyze the methylation profiles of tissue samples from patients with thyroid cancer [71,72]. These studies highlighted that PTC has one of the lowest frequency of DNA methylation alterations [73], while ATC exhibits a frequency of DNA methylation alterations which was 10 fold that of PTC [74] Nitrate exposition with the consequent NO overproduction could represent of the causes of alterations in methylation levels: NO treatment on cancer cell lines was shown to induce alteration of methylation patterns although the epigenetic effects through DNA methylation were diverse and contradictory in different lines [75]. A recent paper [76] suggested that NO may interfere with methylation patterns by inhibiting the different isoforms of ten-eleven translocation (TET) enzymes, which are responsible of the active removal of methyl group via the catalysis of 5-methylcytosine (5mC) oxidation to 5-hydroxy-(5hmC), 5-formly, and 5-carboxy [77,78].…”
Section: Thyroid Cancermentioning
confidence: 99%
“…Successively, several array-based studies using different platforms have been performed to analyze the methylation profiles of tissue samples from patients with thyroid cancer [71,72]. These studies highlighted that PTC has one of the lowest frequency of DNA methylation alterations [73], while ATC exhibits a frequency of DNA methylation alterations which was 10 fold that of PTC [74] Nitrate exposition with the consequent NO overproduction could represent of the causes of alterations in methylation levels: NO treatment on cancer cell lines was shown to induce alteration of methylation patterns although the epigenetic effects through DNA methylation were diverse and contradictory in different lines [75]. A recent paper [76] suggested that NO may interfere with methylation patterns by inhibiting the different isoforms of ten-eleven translocation (TET) enzymes, which are responsible of the active removal of methyl group via the catalysis of 5-methylcytosine (5mC) oxidation to 5-hydroxy-(5hmC), 5-formly, and 5-carboxy [77,78].…”
Section: Thyroid Cancermentioning
confidence: 99%